Gene · 11102
RPP14: ribonuclease P/MRP subunit p14
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RPP14: ribonuclease P/MRP subunit p14. Genes, record 11102. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/11102
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O95059 | Ribonuclease P protein subunit p14 | 124 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents54
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 11446398 B2 | 2022-09-20 | 73708 | O95059 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 73709 | O95059 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 73710 | O95059 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 176679 | O95059 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 176680 | O95059 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 176681 | O95059 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 9779 | O95059 | Espacenet |
| JP 2019033757 A | 2019-03-07 | 24235 | O95059 | Espacenet |
| JP 2019033757 A | 2019-03-07 | 24236 | O95059 | Espacenet |
| JP 2019033757 A | 2019-03-07 | 24237 | O95059 | Espacenet |
1 to 10 of 54
See all 54 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants928
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RPP14 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| T32AI007405 | Training Program in Immunology | 4 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 3 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 2 | 2025 |
| P30CA240139 | The Sylvester Cancer Center Support Grant | 2 | 2025 |
| P30DK020579 | Diabetes Research Center | 2 | 2025 |
| R01AI066232 | Regulation of memory CD8 T cell development | 2 | 2025 |
| R01CA093729 | Repair of Genome Destabilizing DNA Structures | 2 | 2025 |
1 to 10 of 928Source NIH's project files
See all 928 nih grantsPapers1,319
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synergistic p53 Pathway Activation Through Sono-Gene Therapy Induced by Ultrasound-Triggered Theranostic Mesoporous Nanoparticles. | Adv Sci (Weinh) | 2026 | 42544847 | PubTator, text mining | PubMed |
| Viral syncytia evolve to resist interferon. | Nat Commun | 2026 | 42477325 | PubTator, text mining | PubMed |
| TRNAU1AP and PRPF39 establish integrated control over processing of most abundant human non-coding RNAs. | Nat Commun | 2026 | 42277007 | PubTator, text mining | PubMed |
| Heparan sulfate as an attachment factor for ASFV is restricted by host HB-EGF. | Cell Mol Life Sci | 2026 | 41870679 | PubTator, text mining | PubMed |
| Viral and Host Factors Involved in Host Gain and Host Loss by Tomato Leaf Curl Begomoviruses in Tomato and Cucumbers. | Mol Plant Pathol | 2026 | 41761047 | PubTator, text mining | PubMed |
| Elm Blunervirus 1: A Novel Hexapartite Blunervirus Infecting Ulmus parvifolia in China. | Viruses | 2026 | 41754609 | PubTator, text mining | PubMed |
| MMTV-like Viruses and Human Breast Cancer: Evidence for Causality. | Curr Issues Mol Biol | 2026 | 41751420 | PubTator, text mining | PubMed |
| Nuclear coat protein drives a multifaceted tolerance program during Turnip crinkle virus infection. | Res Sq | 2026 | 41727602 | PubTator, text mining | PubMed |
| Differences and commonalities in barriers and facilitators experienced by participants enrolled in an online behavioral weight management program: A qualitative comparison. | PLoS One | 2026 | 41628140 | PubTator, text mining | PubMed |
| Dynamical network analysis reveals long-range residue couplings at the pMHC interface underlying enhanced immunogenicity. | NPJ Syst Biol Appl | 2026 | 41605957 | PubTator, text mining | PubMed |
1 to 10 of 1,319
See all 1,319 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/11102
GET https://conductscience.org/api/genes/v1/11102/patents?page=2